tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Tanaka K et al. Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases. 2014 J. Hum. Genet. pmid:24352002
Gołębiewska J et al. Tako-tsubo cardiomyopathy on the first day after renal transplantation - case report and literature review. 2014 Transplant. Proc. pmid:25380951
Ünlüsoy Aksu A et al. Immune thrombocytopenic purpura in a liver transplant patient. 2014 Exp Clin Transplant pmid:24635822
Bakkour W et al. Successful use of dapsone for the management of circinate balanitis. 2014 Clin. Exp. Dermatol. pmid:24635073
Kapoor K et al. Lip hypertrophy due to cyclosporine therapy. 2014 Clin. Exp. Nephrol. pmid:23615783
Xu H et al. The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. 2014 Am. J. Transplant. pmid:24472192
Lankarani KB et al. Response to: Comment on: New-onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose. 2014 Exp Clin Transplant pmid:24471728
Kuypers DR et al. Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. 2014 Pharmacogenet. Genomics pmid:25322286
Grillo E et al. Necrobiosis lipoidica. 2014 Aust Fam Physician pmid:24600675
Kimura Y et al. Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs. 2014 Toxicol In Vitro pmid:24603311
Demmers MW et al. Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells. 2014 Transplantation pmid:24704664
Størset E et al. Importance of hematocrit for a tacrolimus target concentration strategy. 2014 Eur. J. Clin. Pharmacol. pmid:24071959
Sun Z et al. Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics. 2014 Int Urol Nephrol pmid:25145781
Dannhorn E et al. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up. 2014 Clin Transplant pmid:25142496
Feliu J et al. Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. 2014 Br. J. Haematol. pmid:24962133
Grossman J et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. 2014 Biol. Blood Marrow Transplant. pmid:25111582
Kaieda S et al. Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus. 2014 Mod Rheumatol pmid:24593214
Little JA et al. The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood. 2014 J. Rheumatol. pmid:24085549
Matin M et al. The effectiveness of excimer laser on vitiligo treatment in comparison with a combination therapy of Excimer laser and tacrolimus in an Iranian population. 2014 J Cosmet Laser Ther pmid:25046236
de la Fuente V et al. Calcineurin phosphatase as a negative regulator of fear memory in hippocampus: control on nuclear factor-κB signaling in consolidation and reconsolidation. 2014 Hippocampus pmid:25043904
Qi H et al. Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis. 2014 J. Ind. Microbiol. Biotechnol. pmid:24965502
Jannot M et al. Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge. 2014 Ann. Transplant. pmid:24999809
Wannhoff A et al. Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. 2014 Transplantation pmid:25022236
Nafar M et al. Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients. 2014 Iran J Kidney Dis pmid:24878947
van Gelder T Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation. 2014 Kidney Int. pmid:24875549
Maeda H et al. Disappearance of GFP-positive hepatocytes transplanted into the liver of syngeneic wild-type rats pretreated with retrorsine. 2014 PLoS ONE pmid:24796859
Du W et al. Improved FK506 production by the precursors and product-tolerant mutant of Streptomyces tsukubaensis based on genome shuffling and dynamic fed-batch strategies. 2014 J. Ind. Microbiol. Biotechnol. pmid:24788378
Nkongolo S et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. 2014 J. Hepatol. pmid:24295872
Gillard P et al. Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. 2014 Transplantation pmid:24770614
Pandey S et al. Metabotropic glutamate receptor 1 recycles to the cell surface in protein phosphatase 2A-dependent manner in non-neuronal and neuronal cell lines. 2014 J. Neurochem. pmid:25113668
Madian AG et al. Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution. 2014 BMC Pharmacol Toxicol pmid:25472557
Heilman RL et al. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. 2013 Sep-Oct Clin Transplant pmid:23924146
Benoit S and Hamm H Psoriasis from a prosthesis: unusual Koebner phenomenon in a girl with autoamputation of the leg. 2013 Sep-Oct Pediatr Dermatol pmid:23360396
Zahdi MR et al. Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. 2013 Sep-Oct An Bras Dermatol pmid:24173187
Riva N et al. [Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation]. 2013 Nov-Dec Farm Hosp pmid:24256007
Brodrick B et al. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. 2013 Nov-Dec Clin. Dermatol. pmid:24160287
Bloom RD et al. A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. 2013 Nov-Dec Clin Transplant pmid:24118450
Labirua-Iturburu A et al. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. 2013 May-Jun Clin. Exp. Rheumatol. pmid:23465087
Chen SY et al. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study. 2013 May-Jun Clin Transplant pmid:23432535
Ramirez CB et al. Completely steroid-free immunosuppression in liver transplantation: a randomized study. 2013 May-Jun Clin Transplant pmid:23621629
Krishna N et al. Tacrolimus-induced paranoid delusions and fugue-like state. 2013 May-Jun Gen Hosp Psychiatry pmid:22959421
He L et al. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. 2013 May-Jun J. Nephrol. pmid:22956434
Kanzelmeyer NK et al. Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens. 2013 Mar-Apr Clin Transplant pmid:23414365
Tiwari R et al. Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population. 2013 Mar-Apr J Am Med Inform Assoc pmid:22813760
Albekairy A et al. Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients. 2013 Mar-Apr Saudi J Gastroenterol pmid:23481136
LaMattina JC et al. Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up. 2013 Mar-Apr Clin Transplant pmid:23294013
Alfson ED et al. Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. 2013 Mar-Apr Psychosomatics pmid:22705183
Yoshida EM et al. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection. 2013 Mar-Apr Ann Hepatol pmid:23396740
Castillo G et al. [Acute cellular rejection in a liver transplantation patient due to changing the brand of a generic immunosuppressant]. 2013 Jul-Sep Rev Gastroenterol Mex pmid:23866966
Bechstein WO et al. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients. 2013 Jul-Aug Transplant. Proc. pmid:23953523
Zhao YJ et al. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis. 2013 Jul-Aug Transplant. Proc. pmid:23953533
Weiler N et al. Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? 2013 Jul-Aug Transplant. Proc. pmid:23953543
Stringa P et al. Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. 2013 Jul-Aug Transplant. Proc. pmid:23953566
Tachibana A et al. Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. 2013 Jul-Aug Xenotransplantation pmid:23683097
Favi E et al. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 2013 Jul-Aug Clin Transplant pmid:23710603
Eberlin M et al. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. 2013 Jul-Aug Transplant. Proc. pmid:23726723
Satyanarayan HS et al. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. 2013 Jul-Aug Indian J Dermatol Venereol Leprol pmid:23760325
Babalola O and Strober BE Treatment of atopic dermatitis in pregnancy. 2013 Jul-Aug Dermatol Ther pmid:23914886
Conti R et al. Jessner-Kanof disease: two effective and sure therapeutic options. 2013 Jul-Aug Dermatol Ther pmid:23914897
Chakkera HA et al. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375287
Tian Ch et al. B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375291
Yao B et al. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. 2013 Jan-Feb Transplant. Proc. pmid:23375298
Miyazaki T et al. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375323
Chang HY et al. Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. 2013 Jan-Feb Transplant. Proc. pmid:23375324
Al Nahdi N et al. First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. 2013 Jan-Feb Ann Hepatol pmid:23293209
Seco-Melantuche R et al. [Incidence of drug-induced thrombocytopenia in hospitalized patients]. 2013 Jan-Feb Farm Hosp pmid:23461497
Rao V et al. A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus. 2013 Jan-Feb Transplant. Proc. pmid:23267806
Langone A et al. Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. 2013 Jan-Feb Clin Transplant pmid:22861144
Shiba H et al. Switching from tacrolimus to cyclosporine A to prevent primary biliary cirrhosis recurrence after living-donor liver transplantation. 2013 Apr-Jun Int Surg pmid:23701152
Adamu B et al. New-onset diabetes after renal transplantation: a case series as seen in a Nigerian kidney transplant population. 2013 Apr-Jun Niger J Clin Pract pmid:23563475
Cangemi G et al. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood. 2013 Apr-Jun Int J Immunopathol Pharmacol pmid:23755756
Uslu Gokceoglu A et al. Hyperuricemia in pediatric renal transplant recipients. 2013 Exp Clin Transplant pmid:24344940
Peddi VR et al. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation. 2013 Transplant Rev (Orlando) pmid:23932018
Ormaechea-Pérez N et al. Superficial granulomatous pyoderma. Report of 2 cases treated with topical tacrolimus. 2013 Actas Dermosifiliogr pmid:23933249
Bock ME et al. Treatment of childhood nephrotic syndrome with long-term, low-dose tacrolimus. 2013 Clin. Nephrol. pmid:23380387
Andrades KM et al. Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. 2013 Transplantation pmid:23380869
Ali MN et al. Case series: hemolytic uremic syndrome--another cause of transplant dysfunction. 2013 Transplant. Proc. pmid:24182801
Chen YL et al. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. 2013 PLoS ONE pmid:23472097
Tsukamoto H et al. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus. 2013 Eur J Gastroenterol Hepatol pmid:23411870
Zhang J et al. Helminth protein vaccine induced follicular T helper cell for enhancement of humoral immunity against Schistosoma japonicum. 2013 Biomed Res Int pmid:24308005
Gordon S et al. Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria. 2013 Hawaii J Med Public Health pmid:24052913
Bouamar R et al. Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). 2013 Am. J. Transplant. pmid:23480233
Kanzaki T et al. Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis. 2013 Rheumatol. Int. pmid:22806421
Watanabe M et al. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. 2013 Transplantation pmid:23860082
Kim YC et al. Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy. 2013 PLoS ONE pmid:23977072
Bumbacea RS and Ghiordanescu I Atopic dermatitis induced by systemic immunosupression with tacrolimus--case report. 2013 Eur Ann Allergy Clin Immunol pmid:23862401
Zhang JJ et al. Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers. 2013 Eur. J. Clin. Pharmacol. pmid:23097010
Wang NK et al. Origin of fundus hyperautofluorescent spots and their role in retinal degeneration in a mouse model of Goldmann-Favre syndrome. 2013 Dis Model Mech pmid:23828046
Li X et al. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure. 2013 Nephrol. Dial. Transplant. pmid:23787554
Zahn A et al. Mycophenolate mofetil combination therapy improves survival after liver transplantation. A single-center retrospective analysis. 2013 Ann. Transplant. pmid:24088725
Rodriguez-Rodriguez AE et al. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. 2013 Am. J. Transplant. pmid:23651473
Yuan H et al. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. 2013 Pharmacology pmid:23652322
Tirado-Sánchez A and Ponce-Olivera RM Tacrolimus in confluent and reticulated papillomatosis of Gougerot Carteaud. 2013 Int. J. Dermatol. pmid:22512695
Rerknimitr P et al. Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study. 2013 J Eur Acad Dermatol Venereol pmid:22324720
Barequet IS et al. Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model. 2013 Graefes Arch. Clin. Exp. Ophthalmol. pmid:23553288
Moore LW Food, food components, and botanicals affecting drug metabolism in transplantation. 2013 J Ren Nutr pmid:23611558
Ramos E et al. Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome. 2013 Pediatr Transplant pmid:23730927
Zhao W et al. Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children. 2013 Eur. J. Clin. Pharmacol. pmid:23208323
Tavira B et al. A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients. 2013 Pharmacogenet. Genomics pmid:23778326
Lieber SR and Volk ML Non-adherence and graft failure in adult liver transplant recipients. 2013 Dig. Dis. Sci. pmid:23053889